Tumor stem cells fuse with monocytes to form highly invasive tumor-hybrid cells.


Journal

Oncoimmunology
ISSN: 2162-4011
Titre abrégé: Oncoimmunology
Pays: United States
ID NLM: 101570526

Informations de publication

Date de publication:
16 06 2020
Historique:
entrez: 14 9 2020
pubmed: 15 9 2020
medline: 15 9 2020
Statut: epublish

Résumé

The 'cancer cell fusion' theory is controversial due to the lack of methods available to identify hybrid cells and to follow the phenomenon in patients. However, it seems to be one of the best explanations for both the origin and metastasis of primary tumors. Herein, we co-cultured lung cancer stem cells with human monocytes and analyzed the dynamics and properties of tumor-hybrid cells (THC), as well as the molecular mechanisms beneath this fusion process by several techniques: electron-microscopy, karyotyping, CRISPR-Cas9, RNA-seq, immunostaining, signaling blockage, among others. Moreover, mice models were assessed for

Identifiants

pubmed: 32923132
doi: 10.1080/2162402X.2020.1773204
pii: 1773204
pmc: PMC7458638
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

1773204

Informations de copyright

© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.

Références

PLoS One. 2009 Sep 17;4(9):e7067
pubmed: 19759906
J Cell Sci. 2009 Feb 15;122(Pt 4):453-9
pubmed: 19155290
Sci Rep. 2016 Apr 12;6:23978
pubmed: 27068479
Cell Death Discov. 2017 Jan 23;3:16105
pubmed: 28179999
J Clin Oncol. 2013 Oct 20;31(30):3800-6
pubmed: 24043751
Mediators Inflamm. 2015;2015:235797
pubmed: 26294848
Mediators Inflamm. 2018 May 28;2018:7373921
pubmed: 29997451
Melanoma Res. 2000 Dec;10(6):507-14
pubmed: 11198471
Cancer Res. 2000 May 1;60(9):2512-9
pubmed: 10811133
Cancer Res. 2001 Jan 1;61(1):333-8
pubmed: 11196183
Nature. 1974 Aug 23;250(5468):649-51
pubmed: 4859359
Bone Marrow Transplant. 2004 Jul;34(2):183-6
pubmed: 15195072
Crit Rev Oncog. 2013;18(1-2):43-73
pubmed: 23237552
Cancer Res. 2019 Jun 15;79(12):3011-3027
pubmed: 31053634
PLoS One. 2017 Jul 18;12(7):e0181211
pubmed: 28719656
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
J Clin Oncol. 2010 Dec 10;28(35):5132-9
pubmed: 21060033
PLoS One. 2013 Jun 26;8(6):e66731
pubmed: 23840523
Int J Cancer. 2003 Aug 20;106(2):153-9
pubmed: 12800188
J Immunol. 2009 May 15;182(10):6494-507
pubmed: 19414804
Nature. 2016 Jan 21;529(7586):298-306
pubmed: 26791720
Nature. 2014 Sep 25;513(7519):559-63
pubmed: 25043024
Mediators Inflamm. 2016;2016:9012369
pubmed: 26980947
Nat Rev Cancer. 2008 May;8(5):377-86
pubmed: 18385683
Ther Adv Med Oncol. 2011 Sep;3(5):233-43
pubmed: 21957430
Mol Cell Biol. 1983 Apr;3(4):523-38
pubmed: 6687920
Adv Anat Pathol. 2019 Jan;26(1):69-74
pubmed: 30339548
Breast Cancer Res. 2008;10 Suppl 1:S2
pubmed: 19091006
Cardiovasc Res. 2017 Jun 1;113(7):e16-e17
pubmed: 28525916
J Cancer. 2015 May 23;6(7):623-31
pubmed: 26078792
Cell. 2009 Dec 24;139(7):1315-26
pubmed: 20064377
Oncotarget. 2017 May 26;8(46):81558-81571
pubmed: 29113414
Bone Marrow Transplant. 2005 May;35(10):1021-4
pubmed: 15778726
Cell Adh Migr. 2015;9(5):345-56
pubmed: 26312653
Oncotarget. 2017 Apr 18;8(33):55632-55645
pubmed: 28903450
Cells. 2018 Dec 29;8(1):
pubmed: 30597927
Lancet. 2013 Aug 24;382(9893):709-19
pubmed: 23972814
Circulation. 2000 Jul 4;102(1):82-7
pubmed: 10880419
Oncotarget. 2017 May 18;8(31):51370-51386
pubmed: 28881654
Cancer Discov. 2020 Jan;10(1):86-103
pubmed: 31601552
Front Immunol. 2012 Nov 09;3:335
pubmed: 23162553
PLoS One. 2015 Aug 12;10(8):e0134320
pubmed: 26267609
Redox Biol. 2014 Apr 18;2:786-94
pubmed: 25009780
Nat Commun. 2019 Feb 15;10(1):766
pubmed: 30770823
Stem Cells. 2014 Jul;32(7):1746-58
pubmed: 24737733
Int J Cancer. 1984 Nov 15;34(5):699-707
pubmed: 6500746
Semin Cell Dev Biol. 2017 Jul;67:3-10
pubmed: 28077297
Molecules. 2018 Jul 25;23(8):
pubmed: 30044410
PLoS One. 2017 Apr 26;12(4):e0176460
pubmed: 28445506
FASEB J. 2015 Sep;29(9):4036-45
pubmed: 26085132
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Sci Adv. 2018 Sep 12;4(9):eaat7828
pubmed: 30214939
Curr Protoc Cytom. 2010 Jul;Chapter 10:Unit10.17
pubmed: 20578106
Nature. 2017 Jan 5;541(7635):41-45
pubmed: 27974793
Clin Chim Acta. 2010 Dec 14;411(23-24):1875-82
pubmed: 20816951
Exp Cell Res. 2012 Feb 15;318(4):326-35
pubmed: 22178238
Nat Immunol. 2020 Mar;21(3):298-308
pubmed: 32066953
Cancer Med. 2014 Oct;3(5):1099-111
pubmed: 24961511
Int J Mol Sci. 2020 Mar 09;21(5):
pubmed: 32182935
J Clin Cell Immunol. 2015 Dec;6(6):
pubmed: 26962470

Auteurs

Luis Augusto Aguirre (LA)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Karla Montalbán-Hernández (K)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.

José Avendaño-Ortiz (J)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Centre for Biomedical Research Network of Respiratory Diseases (CIBERES), Madrid, Spain.

Elvira Marín (E)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Roberto Lozano (R)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Víctor Toledano (V)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Centre for Biomedical Research Network of Respiratory Diseases (CIBERES), Madrid, Spain.

Laura Sánchez-Maroto (L)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Verónica Terrón (V)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Jaime Valentín (J)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Elisa Pulido (E)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.

José Carlos Casalvilla (JC)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Carolina Rubio (C)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Luke Diekhorst (L)

Department of Neurology and Stroke Centre, Neuroscience and Cerebrovascular Research Laboratory, IdiPAZ, La Paz University Hospital, Autonomous University of Madrid, Madrid, Spain.

Fernando Laso-García (F)

Department of Neurology and Stroke Centre, Neuroscience and Cerebrovascular Research Laboratory, IdiPAZ, La Paz University Hospital, Autonomous University of Madrid, Madrid, Spain.

Carlos Del Fresno (C)

Immunobiology Laboratory, National Centre for Cardiovascular Research (CNIC), Madrid, Spain.

Ana Collazo-Lorduy (A)

Oncology Department, Research Foundation HM Hospitals, Madrid, Spain.

Beatriz Jiménez-Munarriz (B)

Oncology Department, Research Foundation HM Hospitals, Madrid, Spain.

Paloma Gómez-Campelo (P)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Emilio Llanos-González (E)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.

María Fernández-Velasco (M)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Centre for Biomedical Research Network, CIBER-CV, Madrid, Spain.

Carlos Rodríguez-Antolín (C)

Biomarkers and Experimental Therapeutics in Cancer Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Rebeca Pérez de Diego (R)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Laboratory of Immunogenetics of Human Diseases, IdiPAZ, Madrid, Spain.

Ramón Cantero-Cid (R)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Enrique Hernádez-Jimenez (E)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Enrique Álvarez (E)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Rocío Rosas (R)

Biomarkers and Experimental Therapeutics in Cancer Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Blanca Dies López-Ayllón (B)

Biomarkers and Experimental Therapeutics in Cancer Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Laboratory of Experimental Models of Human Diseases, Biomedical Research Institute CSIC/UAM, Madrid, Spain.
Centre for Biomedical Research Network, CIBERER, Madrid, Spain.

Javier de Castro (J)

Biomarkers and Experimental Therapeutics in Cancer Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Stefanie K Wculek (SK)

Immunobiology Laboratory, National Centre for Cardiovascular Research (CNIC), Madrid, Spain.

Carolina Cubillos-Zapata (C)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Centre for Biomedical Research Network of Respiratory Diseases (CIBERES), Madrid, Spain.

Inmaculada Ibáñez de Cáceres (I)

Biomarkers and Experimental Therapeutics in Cancer Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Prudencio Díaz-Agero (P)

Thoracic Surgery Service, IdiPAZ, La Paz University Hospital, Madrid, Spain.

María Gutiérrez Fernández (M)

Department of Neurology and Stroke Centre, Neuroscience and Cerebrovascular Research Laboratory, IdiPAZ, La Paz University Hospital, Autonomous University of Madrid, Madrid, Spain.

María Paz de Miguel (M)

Cell Engineering Laboratory, IdiPAZ, La Paz University Hospital, Madrid, Spain.

David Sancho (D)

Immunobiology Laboratory, National Centre for Cardiovascular Research (CNIC), Madrid, Spain.

Leon Schulte (L)

Institute for Lung Research/iLung, Research Group "Rna-biology of Inflammation & Infection," Philipps University, Marburg, Germany.

Rosario Perona (R)

Biomarkers and Experimental Therapeutics in Cancer Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Laboratory of Experimental Models of Human Diseases, Biomedical Research Institute CSIC/UAM, Madrid, Spain.
Centre for Biomedical Research Network, CIBERER, Madrid, Spain.

Cristóbal Belda-Iniesta (C)

Oncology Department, Research Foundation HM Hospitals, Madrid, Spain.

Lisardo Boscá (L)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Centre for Biomedical Research Network, CIBER-CV, Madrid, Spain.
Laboratory of Experimental Models of Human Diseases, Biomedical Research Institute CSIC/UAM, Madrid, Spain.

Eduardo López-Collazo (E)

The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Tumour Immunology Lab, IdiPAZ, La Paz University Hospital, Madrid, Spain.
Centre for Biomedical Research Network of Respiratory Diseases (CIBERES), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH